drugset / Trial / NCT02764268

Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer

NCT02764268

Completed 60 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupTreatment

Summary

Apatinib dose titration in Advanced or Metastatic Gastric Cancer

Timeline

Start
2016-11-02
Primary completion
2018-12-10
Completion
2019-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Rivoceranib Small molecule 500 mg Oral
Subject Rivoceranib Small molecule 750 mg Oral
Subject Rivoceranib Small molecule 850 mg Oral

Indications